The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List


Thu, Apr 17, 3:30 PM, Zacks
Edwards Lifesciences Raised to Buy - Analyst Blog
Zacks Investment Research upgraded Edwards Lifesciences to a Zacks Rank 2 (Buy).

Tue, Apr 15, 1:10 PM, Zacks
Edwards Lifesciences' Gain, Medtronic in Pain - Analyst Blog
Shares of Edwards Lifesciences surging in the wake of a favorable ruling by U.S. District Court for the District of Delaware.

Medtronic, Inc. (MDT)

Medtronic is a medical technology company. Co. provides products and therapies for use by medical personnel. Primary products include those for cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, diabetes, and ear, nose, and throat conditions. Co. functions in two operating segments: cardiac and vascular group; and restorative therapies group. Co.'s Cardiac and Vascular Group consists of cardiac rhythm disease management, coronary, structural heart, and endovascular. Co.'s Restorative Therapies Group consists of spine, neuromodulation, diabetes, and surgical technologies.

Company Name:  Medtronic, Inc.
Sector:  Medical Instruments & Supplies
Number of ETFs Holding MDT:  81
Total Market Value Held by ETFs:  $2.54B
Total Market Capitalization:  $58.54B
% of Market Cap. Held by ETFs:  4.34%

April 18, 2014    2:10 PM Eastern

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes

Trade MDT Now:

Buy (2.78 out of 4)
35th percentile
(ranked lower than approx. 65% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Medtronic, Inc. (MDT) Page | The Online Investor | | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.